Considering adaptive designs? Ensure you and your CRO fully understand what adaptive clinical trials are and the pros and cons of using them.

/PRNewswire-PRWeb/ -- OpenClinica debuts eConsent, a complete digital consent solution for improved efficiency, access and patient engagement in clinical...

Public health officials in Argentina questioned the logic of vaccination programs in countries like the United States. They proposed that doses be given within the context of clinical trials.

How to help patients who want to participate and assuage concerns for those who don't

To compare the use of randomized controls (RCTs) and historical controls (HCTs) for clinical trials, we searched the literature for therapies studied …

Cancer clinical trials in the United States appear to be rebounding after a significant slowdown during the pandemic, researchers say.

A Long COVID researcher outlines the key areas essential to the success of all new clinical trials investigating the condition.

Join this channel to get access to perks:https://www.youtube.com/channel/UCDukC60SYLlPwdU9CWPGx9Q/joinNeura Pod is a series covering topics related to Neural...

Here's a guide to understanding endpoints you will likely encounter in cancer clinical trials.

Barriers to participation include suspicion of doctors, religion, health illiteracy, and lack of understanding of clinical trials.

Human clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna's successful COVID-19 vaccine, the drug company announced this week.

Randomized clinical trials are successful because they do not mimic clinical practice. They remain highly clinically relevant despite this.

The federal crackdown on DEI initiatives is unlikely to deter companies from designing more representative trials, as it's 'good science, good ethics, and good business,' one expert said.

The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for preventing wrinkles have reached the testing phase.

The biotechnology industry is on the brink of making advances that will amount to secular miracles, from restoring sight to the blind[1] to exorcising cancer through gene-edited immune cells.[2] That progress is threatened, however, by the extremely high, and rapidly increasing, cost of running clinical trials. If we do not bring these costs down, we […]

To ensure that all kinds of patients get drugs and devices that are safe and effective for them, they need to be represented in clinical trials, but a new study shows that representation of women continues to lag.

Older patients are underrepresented in clinical trial research. Here's how we can change that

The FDA is announcing the availability of a draft guidance with updated recommendations for good clinical practices aimed at modernizing the design and conduct of clinical trials.

FDA wants researchers conducting clinical trials to submit a plan on how they will diversify participant pools. While the effort to undo underrepresentation is appreciated, many say it's not enough.

New estimates suggest that more adults with cancer are participating in cancer trial research, especially at National Cancer Institute–designated centers, but overall enrollment rates remain low.